Skip Navigation
Skip to contents

대한간학회


프로그램

일시: 2024.10.12 (토)
장소: 서울대병원 윤덕병홀

08:55-09:00 Opening Remark 장병국 (지방간연구회 회장)
09:00-09:05 Welcoming Remark 권영오 (대한간학회 회장)
09:05-09:10 Congratulatory Remark 김윤준 (대한간학회 이사장)
Session 1. How can we utilize patient-derived samples in SLD research? 좌장: 권영오 (경북의대)
박상훈 (한림의대)
09:10-09:30 Blood-based miRNA/protein biomarkers for prediction of at-risk MASH 이영선 (고려의대)
09:30-09:50 Pathogenesis and treatment strategies of MASLD focusing on hepatocytes 정영미 (부산대 자연과학대)
09:50-10:10 Diagnosis and evaluation of MAFLD/MASLD according to Chinese guideline Jian-Gao Fan (Shanghai Jiao Tong University, China)
10:10-10:30 Immunological Researches for Novel Target Discovery in MASLD 성필수 (가톨릭의대)
10:30-10:40 Coffee Break
Session 2. KSSG & ARPSG joint session: Identification of SLD: Metabolic Dysfunction vs. Alcohol 좌장: 장병국 (계명의대)
김원 (서울의대)
10:40-11:00 History of the Nomenclature of SLD and Definition of MASLD 진영주 (인하의대)
11:00-11:20 Pathogenesis of Steatohepatitis in Alcohol-related Liver Disease 서원효 (이화여대 약대)
11:20-11:40 Management of Metabolic Dysfunction in SLD 유정주 (순천향의대)
11:40-12:00 Risk Thresholds for Alcohol Consumption across SLD 김정희 (한림의대)
12:00-13:00 Lunch
Session 3. The Integration of Big Data and Artificial Intelligence in SLD 좌장: 이진우 (인하의대)
이정일 (연세의대)
13:00-13:20 Application of Machine Learning to Identify Clinically Significant Stages in MASLD Ju Dong Yang (Cedars-Sinai Medical Center, US)
13:20-13:40 Big Data Study Integrating Transient Elastography to Predict Liver-Related Outcomes in MASLD 김승업 (연세의대)
13:40-14:00 Design and Interpretation of a Nationwide Population-Based Cohort Study in MASLD 구보경 (서울의대)
14:00-14:20 Artificial Intelligence for Detecting and Quantifying Hepatic Steatosis in Imaging Study 강태욱 (성균관의대)
14:20-14:30 Coffee Break
Session 4. Advances in the Management of SLD 좌장: 조용균 (성균관의대)
김형준 (중앙의대)
14:30-14:50 Nutritional Intervention and Prescription for MASLD 허양임 (차의대)
14:50-15:10 Role of Endoscopic Bariatric and Metabolic Therapist on Obesity and MASLD 이상표 (한양의대)
15:10-15:30 The Impact of Microbiome on SLD: a Potential Therapeutic Target 유현주 (서울대 생활과학대)
15:30-15:50 New and Emerging Treatments for Metabolic Dysfunction-associated Steatohepatitis 정승원 (순천향의대)
15:50-16:00 Closing Remark 손 원 (지방간연구회 학술이사)

문의처

          지방간연구회 운영사무국